Safety, Tolerability, and Efficacy of AXA1125 in NASH With Fibrosis

NCT04880187 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Non Alcoholic Steatohepatitis (NASH)

Interventions

DRUG: AXA1125
DRUG: Placebo

Sponsor

Axcella Health, Inc